Objective: To develop a simple extractionless method for detection of rosiglitazone in canine plasma and test the method in a pharmacokinetic study after oral administration of rosiglitazone in dogs.
Animals: 3 client-owned dogs with cancer.
Procedures: High-performance liquid chromatography-tandem mass spectrometry was performed on canine plasma.